NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/jef-feeley/
Sign In To follow
The Pfizer settlements come as GSK, a previous Zantac manufacturer, defends itself in an ongoing trial, while Sanofi, which recalled the drug in 2019 over cancer claims, agreed to pay more than $100 million to resolve its Zantac cases.
"Agreements" Musk made with other Twitter investors make him an "interested shareholder" who must wait three years to close the deal, fund says.
Insurers are taking legal action after a Delaware court ruled Chubb didn't have to pay to defend Rite Aid against thousands of lawsuits.
West Virginia plaintiffs want distributors to pay $2.6B to beef up treatment and policing budgets strained by years of opioid overdoses.
Cigna CEO David Cordani allegedly sought to "poison" the deal after failing to secure the top post in the merged company.
The sum includes $6.2 billion on the criminal side and about $5 billion for tax dollars spent battling the U.S. opioid epidemic.
The funds own Walmart shares and allege executives ensured a steady stream of opioids to so-called pill mills.
The Chapter 11 filing on Sunday is designed to short-circuit more than 2,000 lawsuits against Purdue and its owners.
Under the proposal, Purdue will file for bankruptcy, hand itself over to a trust and sell its overseas drugmaker.
The deal resolves only two cases set for trial in October and leaves intact lawsuits filed by more than 2,000 local governments.